Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Rxi Pharmaceuticals Corporation patents


Recent patent applications related to Rxi Pharmaceuticals Corporation. Rxi Pharmaceuticals Corporation is listed as an Agent/Assignee. Note: Rxi Pharmaceuticals Corporation may have other listings under different names/spellings. We're not affiliated with Rxi Pharmaceuticals Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Rxi Pharmaceuticals Corporation-related inventors


Nucleic acid molecules targeting superoxide dismutase 1 (sod1)

Aspects of the invention relate to methods for treating als comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding superoxide dismutase 1 (sod1).. . ... Rxi Pharmaceuticals Corporation

Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality

The present invention relates to rnai constructs and their use in gene silencing. Rnai constructs associated with the invention contain a double stranded region connected to a single stranded region of phosphorothioate modified nucleotides.. ... Rxi Pharmaceuticals Corporation

Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1

The present invention relates to rnai constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.. . ... Rxi Pharmaceuticals Corporation

Inhibition of pcsk9 through rnai

The invention relates to various pcsk9 rnai constructs with gene silencing activities, and uses thereof. The construct has a double-stranded region of 19-49 nucleotides, preferably 25, 26, or 27 nucleotides, and preferably blunt-ended. ... Rxi Pharmaceuticals Corporation

Rna interference in dermal and fibrotic indications

The present invention relates to rnai constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal and fibrotic applications.. . ... Rxi Pharmaceuticals Corporation

Methods for treatment of disorders in the front of the eye utilizing nucleic acid molecules

Aspects of the invention relate to methods for treating an ocular disorder associated with the front of the eye, comprising administering to the eye of a subject in need thereof a therapeutic rna molecule, in an effective amount to treat an ocular disorder associated with the front of the eye.. . ... Rxi Pharmaceuticals Corporation

Methods for treating cancer using nucleic acids targeting mdm2 or mycn

Aspects of the invention relate to methods for treating cancer by administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding mouse double minute 1 homolog (mdm1), mouse double minute 2 homolog (mdm2), mouse double minute 3 homolog (mdm3), mouse double minute 4 homolog (mdm4) or v-myc myelocytomatosis viral related oncogene (mycn) for treating cancer. Further aspects of the invention relate to nucleic acid molecules and compositions comprising nucleic acid molecules.. ... Rxi Pharmaceuticals Corporation

Rna interference in skin indications

The present invention relates to rnai constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.. . ... Rxi Pharmaceuticals Corporation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Rxi Pharmaceuticals Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Rxi Pharmaceuticals Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###